1,500 Shares in Danaher Corporation $DHR Bought by Lewis Asset Management LLC

Key Points

• Lewis Asset Management LLC purchased 1,500 shares of Danaher Corporation, valued at approximately $296,000, during the 2nd quarter, highlighting continued interest in the company's stock by institutional investors.
• Danaher has a consensus rating of "Moderate Buy" from 17 analysts, with target prices ranging from $205 to $275, indicating varying levels of optimism about its future performance.
• The company declared a quarterly dividend of $0.32 per share, which will be paid on October 31st, reflecting a dividend yield of 0.7% and a payout ratio of 27.23%.

Lewis Asset Management LLC bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,500 shares of the conglomerate's stock, valued at approximately $296,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. GHP Investment Advisors Inc. increased its stake in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. Sierra Ocean LLC boosted its holdings in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the first quarter valued at about $31,000. Finally, Dunhill Financial LLC boosted its stake in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have issued reports on DHR shares. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research note on Friday, July 11th. Wells Fargo & Company decreased their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Guggenheim reiterated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Finally, Barclays restated an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $245.91.

Danaher Stock Down 1.5%

Shares of DHR stock opened at $190.30 on Tuesday. The stock has a market cap of $136.26 billion, a P/E ratio of 40.49, a P/E/G ratio of 2.70 and a beta of 0.75. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a 50 day simple moving average of $200.02 and a two-hundred day simple moving average of $198.03. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio is presently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.